Core Viewpoint - The National Medical Products Administration (NMPA) held a meeting to summarize the regulatory achievements of 2025 and outline key work strategies for 2026, emphasizing the importance of high-quality development in the cosmetics industry [2]. Group 1: Regulatory Focus - The meeting highlighted that 2026 marks the beginning of the "14th Five-Year Plan," necessitating the implementation of the spirit of the 20th National Congress and subsequent plenary sessions [2]. - The NMPA aims to deepen the reform of the entire regulatory process and strengthen safety measures across the cosmetics industry [2]. Group 2: Stakeholder Engagement - Representatives from various provincial drug regulatory authorities participated in the meeting, indicating a collaborative approach to regulatory oversight [2]. - During the visit to Shijiazhuang, NMPA officials conducted on-site research at local drug and medical device inspection institutions [2].
国家药监局：持续深化全过程监管改革 全链条促进化妆品产业高质量发展
智通财经网·2025-12-29 06:59